CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI

QR Code

CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI

Show other versions (1)

Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis accompanied by accumulation of mucus and high recurrence rate and in some cases complicated with intestinal obstruction. In the last 10–15 years, there has been observed a significant improvement in overall survival of patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. G. Abdullaev, М. M. Davydov, N. A. Коzlov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-06-01
Series:	Сибирский онкологический журнал
Subjects:	pseudomyxoma peritonei cytoreduction recurrence intraperitoneal chemoperfusion survival relapse intestinal obstruction
Online Access:	https://www.siboncoj.ru/jour/article/view/1099
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Challenges in choice of the treatment strategy for patients with recurrent pseudomyxoma peritonei
by: A. G. Abdullaev, et al.
Published: (2019-04-01)

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01)

The microbiome of pseudomyxoma peritonei: a scoping review
by: Portela D. Sara, et al.
Published: (2025-05-01)

A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei
by: Kenya Yamanaka, et al.
Published: (2021-12-01)

Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin
by: Fengxian Fu, et al.
Published: (2025-07-01)

Endoscopic manifestation of disease progression from low-grade appendiceal mucinous neoplasm to pseudomyxoma peritonei: A case report
by: Yanhong Gao, et al.
Published: (2025-08-01)

Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma
by: Viktor Proesmans, et al.
Published: (2022-12-01)

Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: CT and MRI insights from a rare case
by: Paola Milillo, MD, PhD, et al.
Published: (2025-09-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022-01-01)

Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment
by: G. S. Kireeva, et al.
Published: (2019-02-01)

Intraperitoneal CHEMOPERFUSION TREATMENT OF ADVANCED OVARIAN CANCER WITH DIOXADET COMPARED TO CISPLATIN in experimental s
by: V. G. Bespalov, et al.
Published: (2016-02-01)

PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE
by: S. V. Solomenny, et al.
Published: (2017-02-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis
by: Lee S. Kyang, et al.
Published: (2022-12-01)

Intraoperative photodynamic therapy and hyperthermic intraperitoneal chemotherapy in cytoreductive treatment of patients with disseminated mucinous carcinoma of appendix
by: D. V. Sidorov, et al.
Published: (2021-02-01)

Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)
by: V. A. Markovich, et al.
Published: (2022-01-01)

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)
by: S. I. Radostev, et al.
Published: (2024-06-01)

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines
by: Expert Panel Management of Peritoneal Carcinomatosis, et al.
Published: (2025-07-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Prognostic significance of the logistic regression model for assessing the risk of recurrence in patients with prostate cancer after radical prostatectomy
by: S. A. Reva, et al.
Published: (2022-12-01)

Fluorescence Diagnostics and Photodynamic Therapy in Cytoreductive Surgical Treatment of Peritoneal Carcinomatosis Patient
by: D. A. Rudakov, et al.
Published: (2024-07-01)

Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
by: V. A. Markovich, et al.
Published: (2023-02-01)

Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought
by: Sh. Kh. Gantsev, et al.
Published: (2021-04-01)

Implementation of an enhanced recovery after surgery (ERAS) program in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: study protocol for a prospective multicenter interventional trial (EPICH study)
by: Robella Manuela, et al.
Published: (2025-04-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
by: Bhatt Aditi, et al.
Published: (2024-07-01)

Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
by: Sh. Kh. Gantsev, et al.
Published: (2021-05-01)

Phytobezoar as a Cause of Recurrent Obturation Intestinal Obstruction. A Clinical Case in Surgical Practice
by: A. G. Hasanov, et al.
Published: (2024-10-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

THE VALUE OF CYTOREDUCTIVE SURGERY FOR ISOLATED LYMPH NODE RECURRENCE OF OVARIAN CANCER
by: H. I. Mamajonov, et al.
Published: (2020-07-01)

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study
by: Petersen Elisabeth Krogsgaard, et al.
Published: (2025-04-01)

Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: D. D. Morikov, et al.
Published: (2022-05-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
by: Kozo Miyatani, et al.
Published: (2020-05-01)

Specific features of current intraperitoneal therapy in patients with ovarian cancer
by: A. G. Kedrova, et al.
Published: (2016-06-01)

TO THE PROBLEM OF CHOICE OF THE TREATMENT TACTICS IN METASTATIC COLORECTAL CANCE
by: A. Z. Azanov, et al.
Published: (2016-04-01)

Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy
by: Cheng Xu, et al.
Published: (2025-07-01)

COMPLICATIONS OF ISOLATED REGIONAL LIMB CHEMOPERFUSION
by: G. I. Gafton, et al.
Published: (2016-02-01)

Evaluation of the efficacy of Vesusten® in patients with overactive bladder and chronic recurrent cystitis
by: N. G. Galkina, et al.
Published: (2024-07-01)